Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Lacombe P, Deschênes D, Dubé D, Dubé L, Gallant M, Macdonald D, Mastracchio A, Perrier H, Charleson S, Huang Z, Laliberté F, Liu S, Mancini JA, Masson P, Salem M, Styhler A, Girard Y. Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors. Bioorg Med Chem Lett 2006;16:2608-12. [PMID: 16516471 DOI: 10.1016/j.bmcl.2006.02.043] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2006] [Revised: 02/14/2006] [Accepted: 02/15/2006] [Indexed: 10/24/2022]

For:	Lacombe P, Deschênes D, Dubé D, Dubé L, Gallant M, Macdonald D, Mastracchio A, Perrier H, Charleson S, Huang Z, Laliberté F, Liu S, Mancini JA, Masson P, Salem M, Styhler A, Girard Y. Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors. Bioorg Med Chem Lett 2006;16:2608-12. [PMID: 16516471 DOI: 10.1016/j.bmcl.2006.02.043] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2006] [Revised: 02/14/2006] [Accepted: 02/15/2006] [Indexed: 10/24/2022]

Number

Cited by Other Article(s)

Mukherjee S, Pal M. Quinolines: a new hope against inflammation. Drug Discov Today 2013;18:389-98. [DOI: 10.1016/j.drudis.2012.11.003] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2012] [Revised: 10/12/2012] [Accepted: 11/07/2012] [Indexed: 01/05/2023]

Lacombe P, Chauret N, Claveau D, Day S, Deschênes D, Dubé D, Gallant M, Girard Y, Huang Z, Laliberté F, Lévesque JF, Liu S, Macdonald D, Mancini JA, Masson P, Nicholson DW, Nicoll-Griffith DA, Salem M, Styhler A, Young RN. Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors. Bioorg Med Chem Lett 2009;19:5266-9. [DOI: 10.1016/j.bmcl.2009.03.105] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2009] [Revised: 03/19/2009] [Accepted: 03/23/2009] [Indexed: 10/21/2022]

Kodimuthali A, Jabaris SSL, Pal M. Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. J Med Chem 2008;51:5471-89. [PMID: 18686943 DOI: 10.1021/jm800582j] [Citation(s) in RCA: 129] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]